Medication info
Mirtel Tablets 20 mg (Telmisartan)

Mirtel Tablets 20 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›20mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White or nearly white, biconvex round tablets
Packaging
For domestic use - 30 tablets/box [(10 tablets/PTP) * 3]
Approval status
Active

MFDS item code 202301422 · Approved 2023.05.02 · Insurance code 651206010

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at a dose of 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
View approved original text

This medication helps effectively lower blood pressure in patients with essential hypertension. It is also used in patients aged 55 and older, at high risk of cardiovascular disease, especially those with a history of coronary artery disease or stroke, or those with high-risk diabetes, to reduce the risks of myocardial infarction, stroke, and mortality due to cardiovascular disease. Through these effects, it protects patients' cardiovascular health and reduces overall risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at a dose of 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm, particularly to the fetus and newborns, during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. It should not be used by individuals with allergies to this drug, by pregnant or breastfeeding women, by patients with severe liver impairment, by individuals with specific angioedema, and by patients with diabetes or severe renal impairment. Special precautions should be taken when administering this drug to elderly patients, patients with hyperkalemia, liver disease, valvular heart disease, ischemic heart disease, or other special health conditions. Various adverse reactions such as blood pressure drop, hyperkalemia, renal impairment, angioedema, and liver function abnormalities may occur during treatment, so symptoms should be monitored carefully. Particularly, if symptoms such as a sudden drop in blood pressure or difficulty breathing, swelling of the face or lips occur, medical assistance should be sought immediately. It is important to regularly check potassium and creatinine levels in patients with reduced kidney function when administering this drug. In cases of reduced blood volume or sodium depletion, the risk of hypotension increases, so these conditions should be corrected in advance. Caution is advised when taking this drug with other antihypertensives, specific diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., and consultation with healthcare professionals is recommended. Women who are pregnant or planning to become pregnant should not use this drug, and breastfeeding women should also preferably avoid taking it. It is not recommended for children under 18 years old as safety and effectiveness have not been established. In the case of overdose, symptoms such as hypotension, dizziness, acute renal failure may occur, and immediate medical treatment is required. Keep this medication out of reach of children and ensure it remains sealed until use. Caution is needed when driving or operating machinery as it may cause fainting or dizziness.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 82 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver disorders
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • palpitations
  • nausea
  • inadequate effect
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis
  • vascular edema
  • gastrointestinal bleeding

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best stored at room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White or nearly white, biconvex round tablets

Package unit

For domestic use - 30 tablets/box [(10 tablets/PTP) * 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.